E-075

Estrone solution

Name: Estrone solution
Brand: CERILLIAN
Price: 106.5 USD

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

Slide 1 of 1

Sign Into View Organizational & Contract Pricing

Select a Size

1 ML

$106.50

List Price$142.00Save 25%

Web-Only Promotion

Check Cart for Availability

Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):

C₁₈H₂₂O₂

CAS Number:

53-16-7

Molecular Weight:

270.37

MDL number:

MFCD00003620

UNSPSC Code:

41116107

PubChem Substance ID:

329798986

NACRES:

NA.24

Key Documents

View All Documentation

grade

certified reference material

Quality Level

300

form

liquid

feature

Snap-N-Spike^®/Snap-N-Shoot^®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant^®

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

clinical testing
clinical testing

format

single component solution

storage temp.

−20°C

SMILES string

CC12CCC3C(CCc4cc(O)ccc34)C1CCC2=O

InChI

1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1

InChI key

DNXHEGUUPJUMQT-CBZIJGRNSA-N

Gene Information

human ... ESR1(2099)

Related Categories

Analytical Chemistry

Analytical Chromatography

Biomarker & Metabolite Standards

Certified Reference Materials

Chromatography Standards

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	PHR1535	BP860	E1700000
Supelco E-075 Estrone solution	Supelco PHR1535 Estrone	BP860 Estrone	E1700000 Estrone
technique(s) gas chromatography (GC): suitable, liquid chromatography (LC): suitable	technique(s) HPLC: suitable, gas chromatography (GC): suitable	technique(s) -	technique(s) HPLC: suitable, gas chromatography (GC): suitable
form liquid	form -	form crystalline	form -
format single component solution	format neat	format neat	format neat
Quality Level 300	Quality Level 300	Quality Level -	Quality Level -
grade certified reference material	grade certified reference material, pharmaceutical secondary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard
storage temp. −20°C	storage temp. 2-30°C	storage temp. 2-8°C	storage temp. -

General description

A precursor of estradiol, estrone is monitored in serum or plasma by LC-MS/MS or GC/MS to assess and diagnose developmental abnormalities, enzyme inactivity or deficiency, polycystic ovary syndrome (PCOS), or hormone replacement therapy in women.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

related product

Product No.

Description

Pricing

E-060

17β-Estradiol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

E-061

17β-Estradiol-D₅ solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

E-073

17β-Estradiol-2,3,4-¹³C₃ solution, ampule of 1 mL, Cerilliant^®

E-074

Estriol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

E-076

17α-Ethynylestradiol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

H-126

16α-Hydroxyestrone, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant^®

E-117

17β-Estradiol-2,3,4-¹³C₃ solution, 10 μg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant^®

H-127

2-Hydroxyestrone solution, 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant^®

pictograms

GHS02,GHS06,GHS08

signalword

Danger

hcodes

H225,H301 + H311 + H331,H370

pcodes

P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

Storage Class

3 - Flammable liquids

wgk_germany

WGK 2

flash_point_f

49.5 °F - closed cup

flash_point_c

9.7 °C - closed cup

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Fluctuations in natural and synthetic estrogen concentrations in a tidal estuary in south-eastern Australia.

Emma M Ferguson et al.

Water research, 47(4), 1604-1615 (2013-01-12)

Estuaries are often the final repositories for aquatic pollutants but how estuarine hydrology influences the availability of marine- and freshwater-derived pollutants is not well understood, particularly for micro-pollutants such as endocrine disrupting chemicals. To address this knowledge gap, this study

Steroid sulfatase: a new target for the endocrine therapy of breast cancer.

Susannah J Stanway et al.

The oncologist, 12(4), 370-374 (2007-05-02)

Inhibitors of steroid sulfatase are being developed as a novel therapy for hormone-dependent breast cancer in postmenopausal women. Data suggest that steroid sulfatase (STS) activity is much higher than aromatase activity in breast tumors and high levels of STS mRNA

Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast.

Kiyoshi Ito

The Tohoku journal of experimental medicine, 212(1), 1-12 (2007-04-28)

Hormone replacement therapy (HRT) has become available over the past few decades, but the risk of breast cancer with HRT remains controversial. The Women's Health Initiative Study has recently demonstrated that women receiving estrogen plus progestin (HRT) have an increased

Sex hormone levels and risk of breast cancer with estrogen plus progestin.

Ghada N Farhat et al.

Journal of the National Cancer Institute, 105(19), 1496-1503 (2013-09-18)

Although high endogenous sex hormone levels and estrogen plus progestin (E+P) therapy are associated with increased breast cancer risk, it is unknown whether pretreatment levels of sex hormones modify E+P effect on breast cancer. We conducted a nested case-control study

Oleoyl-estrone.

Xavier Remesar et al.

Medicinal research reviews, 32(6), 1263-1291 (2011-02-03)

Oleoyl-estrone (OE) is a powerful slimming agent that is also present in plasma and adipose tissue, where it is synthesized. It acts through the formation of a derivative W. OE effects (and W levels) are proportional to the dose. OE

View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service